Evidence map›Paper›PMID 32653054›Full record

Observational studyThe Lancet. Child & adolescent health2020

Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study.

Patrick Davies, Claire Evans, Hari Krishnan Kanthimathinathan, Jon Lillie, Joseph Brierley, Gareth Waters, Mae Johnson, Benedict Griffiths, Pascale du Pré, Zoha Mohammad and 14 more

Erratum issued Registry-linked trialOpen access · bronzeAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in The Lancet. Child & adolescent health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT05975671 (Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis), which is not on this map. Cited by 227 papers, 14 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
227citing papers in PubMed, 14 pooled it
86.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05975671 narecruitingnot on this mapstarted 2023, after this paper: background citation

Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis (REVAMP-Sepsis)

TypeinterventionalSponsorChildren's Hospital of PhiladelphiaRan2023 to 2026Enrolled52,500ConditionsSepsis, Sepsis Mrsa, Sepsis Bacteremia, Antimicrobial - Induced NephropathyArmsMultifaceted de-implementation strategy to reduce vancomycin overuse
3 · Its place in the literature

Who cites it

227 citing papers in PubMed, 14 syntheses or guidelines pooled it, 490 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Histopathological findings and clinicopathologic correlation in COVID-19: a systematic review.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021
    Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

167 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 16 institutions in 1 country.

Patrick DaviesPaediatric Critical Care Unit, Nottingham Children's Hospital, Nottingham, UK. Electronic address: patrick.davies@nuh.nhs.uk.
Claire EvansPaediatric Critical Care Unit, Nottingham Children's Hospital, Nottingham, UK.
Hari Krishnan KanthimathinathanPaediatric Intensive Care Unit, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
Jon LilliePaediatric Intensive Care Unit, Evelina Children's Hospital, London, UK.
Joseph BrierleyPaediatric Intensive Care Unit, Great Ormond Street Hospital, London, UK.
Gareth WatersPaediatric Intensive Care Unit, Evelina Children's Hospital, London, UK.
Mae JohnsonPaediatric Intensive Care Unit, Great Ormond Street Hospital, London, UK.
Benedict GriffithsPaediatric Intensive Care Unit, Evelina Children's Hospital, London, UK.
Pascale du PréPaediatric Intensive Care Unit, Great Ormond Street Hospital, London, UK.
Zoha MohammadPaediatric Intensive Care Unit, Leicester Royal Infirmary, Leicester, UK.
Akash DeepPaediatric Intensive Care Unit, King's College Hospital, London, UK.
Stephen PlayforPaediatric Intensive Care Unit, Royal Manchester Children's Hospital, Manchester, UK.
Davinder SinghPaediatric Intensive Care Unit, Leeds Royal Infirmary, Leeds, UK.
David InwaldPaediatric Intensive Care Unit, Addenbrooke's Hospital, Cambridge, UK.
Michelle JardinePaediatric Critical Care Unit, Children's Hospital for Wales, Cardiff, UK.
Oliver RossPaediatric Intensive Care Unit, Southampton Children's Hospital, Southampton, UK.
Nayan ShettyPaediatric Intensive Care Unit, Alder Hey Children's Hospital, Liverpool, UK.
Mark WorrallPaediatric Intensive Care Unit, Royal Hospital for Children, Glasgow, UK.
Ruchi SinhaPaediatric Intensive Care Unit, St Mary's Hospital, London, UK.
Ashwani KoulPaediatric Critical Care Unit, John Radcliffe Hospital, Oxford, UK.
Elizabeth WhittakerPaediatric Infectious Diseases Department, Imperial College Healthcare NHS Trust, London, UK.
Harish VyasPaediatric Critical Care Unit, Nottingham Children's Hospital, Nottingham, UK.
Barnaby R ScholefieldPaediatric Intensive Care Unit, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK; Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Padmanabhan RamnarayanPaediatric Intensive Care Unit, St Mary's Hospital, London, UK; Children's Acute Transport Service, Great Ormond Street Hospital NHS Foundation Trust and NIHR Biomedical Research Centre, London, UK.
Evelina London Children's Healthcare · GBBirmingham Women’s and Children’s NHS Foundation Trust · GBGreat Ormond Street Hospital · GBSt Mary's Hospital · GBAddenbrooke's Hospital · GBImperial College Healthcare NHS Trust · GBJohn Radcliffe Hospital · GBKing's College Hospital · GBLeeds General Infirmary · GBLeicester Royal Infirmary · GBNoah's Ark Children's Hospital for Wales · GBRoyal Hospital for Children · GBRoyal Manchester Children's Hospital · GBSouthampton Children's Hospital · GBUniversity College London · GBUniversity of Liverpool · GB

Funding

Department of Health CS-2015-15-016
6 · The paper itself

Abstract

backgroundIn April, 2020, clinicians in the UK observed a cluster of children with unexplained inflammation requiring admission to paediatric intensive care units (PICUs). We aimed to describe the clinical characteristics, course, management, and outcomes of patients admitted to PICUs with this condition, which is now known as paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS).

methodsWe did a multicentre observational study of children (aged <18 years), admitted to PICUs in the UK between April 1 and May 10, 2020, fulfilling the case definition of PIMS-TS published by the Royal College of Paediatrics and Child Health. We analysed routinely collected, de-identified data, including demographic details, presenting clinical features, underlying comorbidities, laboratory markers, echocardiographic findings, interventions, treatments, and outcomes; serology information was collected if available. PICU admission rates of PIMS-TS were compared with historical trends of PICU admissions for four similar inflammatory conditions (Kawasaki disease, toxic shock syndrome, haemophagocytic lymphohistiocytosis, and macrophage activation syndrome).

findings78 cases of PIMS-TS were reported by 21 of 23 PICUs in the UK. Historical data for similar inflammatory conditions showed a mean of one (95% CI 0·85-1·22) admission per week, compared to an average of 14 admissions per week for PIMS-TS and a peak of 32 admissions per week during the study period. The median age of patients was 11 years (IQR 8-14). Male patients (52 [67%] of 78) and those from ethnic minority backgrounds (61 [78%] of 78) were over-represented. Fever (78 [100%] patients), shock (68 [87%]), abdominal pain (48 [62%]), vomiting (49 [63%]), and diarrhoea (50 [64%]) were common presenting features. Longitudinal data over the first 4 days of admission showed a serial reduction in C-reactive protein (from a median of 264 mg/L on day 1 to 96 mg/L on day 4), D-dimer (4030 μg/L to 1659 μg/L), and ferritin (1042 μg/L to 757 μg/L), whereas the lymphocyte count increased to more than 1·0 × 10

interpretationDuring the study period, the rate of PICU admissions for PIMS-TS was at least 11-fold higher than historical trends for similar inflammatory conditions. Clinical presentations and treatments varied. Coronary artery aneurysms appear to be an important complication. Although immediate survival is high, the long-term outcomes of children with PIMS-TS are unknown.

fundingNone.

Indexed as

BetacoronavirusAdolescentChildCoronavirus InfectionsCOVID-19FemaleHumansIncidenceIntensive Care Units, PediatricMalePandemicsPatient AdmissionPneumonia, ViralSARS-CoV-2Systemic Inflammatory Response SyndromeUnited Kingdom

Identifiers

PMID32653054
PMCPMC7347350
OpenAlexW3041825924

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.